ORIGINAL RESEARCH
Published on 25 Jun 2025
Closed-system manufacturing of therapeutic NK cells using automated cell enrichment and concentration processes enables scalable, robust and cost-effective solutions
doi 10.3389/fbioe.2025.1586912
- 1,138 views